Tag: Skye Bioscience

Skye Bioscience has filed a notice of an exempt offering of securities to raise $40 Million in New Equity Investment.

Skye Bioscience has filed a notice of an exempt offering of securities to raise $40 Million in New Equity Investment.

According to filings with the U.S. Securities and Exchange Commission, Skye Bioscience is raising up to $40,000,000.00 in new funding. Sources indicate that as part of senior management President and Chief Executive Officer, Punit Dhillon…

Read More Read More

Skye Bioscience, Inc has filed a notice of a Private Investment in Public Equity (PIPE) offering of securities to raise $50,250,000.00 in New Funding.

Skye Bioscience, Inc has filed a notice of a Private Investment in Public Equity (PIPE) offering of securities to raise $50,250,000.00 in New Funding.

According to filings with the U.S. Securities and Exchange Commission, Skye Bioscience, Inc. is raising $50,250,000.00 in new funding. About Skye Bioscience, Inc.: Skye Bioscience, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes…

Read More Read More